Vermilion ETF Pathfinder: Actionable ETF research & Ideas
Add Exposure to Small-Caps; Upgrading Health CareBullish price and RS inflections for small-caps (IWM) is the latest positive development underpinning our belief that we are in the early stages of a broad-based market advance.
• Small-Caps. The Russell 2000 (IWM) is decisively breaking topside $160 resistance and is making the long-awaited bullish RS reversal -- add exposure. Bullish price and RS inflections for small-caps helped ignite the broad market rally that began in early 2016, and we believe today's market is poised for a similar outcome... see chart below.
• Health Care. We are upgrading Health Care to overweight due to price breakouts and decisive RS bottoms for cap-weighted (XLV), equal-weighted (RYH) and small-cap Health Care (PSCH). Add exposure... see page 3.
• Late-Stage Cyclicals. Late-stage cyclicals are mixed, with Materials (XLB, SLX, XME) showing signs of bottoming while Energy (RYE, IEO) lags. Energy historically is among the last of the cyclical Sectors to participate in the rally, so we want to remain patient as we expect the Sector to eventually play catch-up... see page 2.
• Actionable Industry ETFs: TAN, IPAY, IGV, and XPH... see page 9.
• EM and Int'l: EM equities (EEM) have deteriorated from a RS perspective, a concerning development that has put a damper on sentiment... see page 10.
• Actionable Int'l ETFs: EWL, EIRL, DXGE, EWUS, ERUS, and KWEB... see pages 11-12.
Vermilion Research delivers timely, actionable, and unique research inputs to professional investors. Our research strategists highlight securities which we believe are at major inflection points, based on our various proprietary technical indicators, and offer asymmetric risk/return profiles. We believe our research methodology, which is not limited by industry sector or market capitalization, enables us to deliver superior investment recommendations.
Our process begins by organizing all actively traded stocks into coherent sectors, then into logical industry groups. We then apply our proprietary relative strength tools to identify developing price trends. Once attractive trends are identified within a selected sectors or groups, we screen for individual stocks which we believe offer the best risk/reward profile. Vermilion offers U.S. and global equity market research products. Vermilion’s research team, which has received numerous awards and accolades, has a combined 70 year of experience in the analysis of investment securities.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.